These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6130865)

  • 1. Desipramine hydroxylation: variability and effect of antipsychotic drugs.
    Bock JL; Nelson JC; Gray S; Jatlow PI
    Clin Pharmacol Ther; 1983 Mar; 33(3):322-8. PubMed ID: 6130865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG; Warsh JJ; Stancer HC; Reed KL; Persad E
    Clin Pharmacol Ther; 1984 Sep; 36(3):343-9. PubMed ID: 6467794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary desipramine hydroxylation index and steady-state plasma concentrations of imipramine and desipramine.
    Spina E; Arena A; Pisani F
    Ther Drug Monit; 1987 Jun; 9(2):129-33. PubMed ID: 3617150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active metabolites of imipramine and desipramine in man.
    Potter WZ; Calil HM; Sutfin TA; Zavadil AP; Jusko WJ; Rapoport J; Goodwin FK
    Clin Pharmacol Ther; 1982 Mar; 31(3):393-401. PubMed ID: 7060321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration monitoring of hydroxylated metabolites of imipramine and desipramine.
    DeVane CL; Jusko WJ
    Drug Intell Clin Pharm; 1981 Apr; 15(4):263-6. PubMed ID: 7274042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of desipramine 2-hydroxylation by quinidine and quinine.
    Steiner E; Dumont E; Spina E; Dahlqvist R
    Clin Pharmacol Ther; 1988 May; 43(5):577-81. PubMed ID: 3365919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical implications of 2-hydroxydesipramine plasma concentrations.
    Nelson JC; Bock JL; Jatlow PI
    Clin Pharmacol Ther; 1983 Feb; 33(2):183-9. PubMed ID: 6822031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes.
    Spina E; Birgersson C; von Bahr C; Ericsson O; Mellström B; Steiner E; Sjöqvist F
    Clin Pharmacol Ther; 1984 Nov; 36(5):677-82. PubMed ID: 6488689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.
    Spina E; Gitto C; Avenoso A; Campo GM; Caputi AP; Perucca E
    Eur J Clin Pharmacol; 1997; 51(5):395-8. PubMed ID: 9049581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant activity of 2-hydroxydesipramine.
    Nelson JC; Mazure C; Jatlow PI
    Clin Pharmacol Ther; 1988 Sep; 44(3):283-8. PubMed ID: 3416551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmethylimipramine overdose: nonlinear kinetics in a slow hydroxylator.
    Spina E; Henthorn TK; Eleborg L; Nordin C; Säwe J
    Ther Drug Monit; 1985; 7(2):239-41. PubMed ID: 4024220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered hydroxydesipramine concentrations in elderly depressed patients.
    Kitanaka I; Ross RJ; Cutler NR; Zavadil AP; Potter WZ
    Clin Pharmacol Ther; 1982 Jan; 31(1):51-5. PubMed ID: 7053304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steady-state plasma concentrations of cis- and trans-10-OH amitriptyline metabolites.
    Bock JL; Giller E; Gray S; Jatlow P
    Clin Pharmacol Ther; 1982 May; 31(5):609-16. PubMed ID: 6122526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine pharmacokinetics in Chinese and Caucasian volunteers.
    Rudorfer MV; Lane EA; Chang WH; Zhang MD; Potter WZ
    Br J Clin Pharmacol; 1984 Apr; 17(4):433-40. PubMed ID: 6721989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose pharmacokinetics of imipramine and its major active and conjugated metabolites in depressed patients.
    Sutfin TA; Perini GI; Molnar G; Jusko WJ
    J Clin Psychopharmacol; 1988 Feb; 8(1):48-53. PubMed ID: 3350999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different regiospecificity in the hydroxylation of the antidepressant desmethylimipramine between rat brain and liver.
    Hansson T; von Bahr C; Marklund M; Svensson JO; Ingelman-Sundberg M; Lundström J
    Pharmacol Toxicol; 1992 Dec; 71(6):416-9. PubMed ID: 1480550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of carbamazepine on the 2-hydroxylation of desipramine.
    Spina E; Avenoso A; Campo GM; Caputi AP; Perucca E
    Psychopharmacology (Berl); 1995 Feb; 117(4):413-6. PubMed ID: 7604141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxydesipramine in the elderly.
    Nelson JC; Atillasoy E; Mazure C; Jatlow PI
    J Clin Psychopharmacol; 1988 Dec; 8(6):428-33. PubMed ID: 3235701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible nonlinear pharmacokinetics of desipramine after once daily dosing.
    Amsterdam JD; Brunswick DJ; Potter L; Rickels K
    Pharmacopsychiatry; 1986 Mar; 19(2):84-7. PubMed ID: 3703927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipramine metabolites in blood of patients during therapy and after overdose.
    Gram LF; Bjerre M; Kragh-Sørensen P; Kvinesdal B; Molin J; Pedersen OL; Reisby N
    Clin Pharmacol Ther; 1983 Mar; 33(3):335-42. PubMed ID: 6825388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.